| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |